爱尔眼科
(300015)
| 流通市值：708.98亿 | | | 总市值：828.79亿 |
| 流通股本：79.39亿 | | | 总股本：92.81亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 18,344,287,400.96 | 11,945,704,579.95 | 6,396,494,547.19 | 22,352,604,724.87 |
| 营业总成本 | 13,914,579,721.96 | 9,126,924,536.72 | 4,825,670,718.98 | 17,711,126,106.58 |
| 其他经营收益 | | | | |
| 营业利润 | 4,231,418,976.35 | 2,820,559,261.95 | 1,597,215,415.15 | 4,603,094,869.1 |
| 利润总额 | 3,982,358,813.33 | 2,596,076,977.99 | 1,567,878,807.31 | 4,425,135,001.83 |
| 净利润 | 2,556,597,060.47 | 1,543,194,862.42 | 1,314,676,256.76 | 3,473,219,216.75 |
| 每股收益 | | | | |
| 其他综合收益 | -277,802,016.92 | -191,809,868.06 | -117,445,268.76 | 223,202,815.2 |
| 综合收益总额 | 2,278,795,043.55 | 1,351,384,994.36 | 1,197,230,988 | 3,696,422,031.95 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 10,749,425,370.57 | 10,279,758,787.5 | 10,098,872,808 | 10,082,514,576.7 |
| 非流动资产: | | | | |
| 非流动资产合计 | 26,671,336,105.34 | 25,959,880,834.13 | 26,482,374,879.67 | 26,593,476,146.02 |
| 资产总计 | 37,420,761,475.91 | 36,239,639,621.63 | 36,581,247,687.67 | 36,675,990,722.72 |
| 流动负债: | | | | |
| 流动负债合计 | 7,658,645,937.77 | 6,952,427,242.31 | 6,994,761,463.7 | 8,142,306,456.65 |
| 非流动负债: | | | | |
| 非流动负债合计 | 5,338,690,890.75 | 4,846,423,371.51 | 4,974,548,857.97 | 5,135,322,040.33 |
| 负债合计 | 12,997,336,828.52 | 11,798,850,613.82 | 11,969,310,321.67 | 13,277,628,496.98 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 22,678,138,003.44 | 23,019,896,841.62 | 23,044,991,535.36 | 21,973,668,007.5 |
| 股东权益合计 | 24,423,424,647.39 | 24,440,789,007.81 | 24,611,937,366 | 23,398,362,225.74 |
| 负债和股东权益合计 | 37,420,761,475.91 | 36,239,639,621.63 | 36,581,247,687.67 | 36,675,990,722.72 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 18,541,543,070.28 | 12,036,258,269.13 | 6,426,852,372.39 | 22,876,326,516.99 |
| 经营活动现金流出小计 | 14,179,362,093.69 | 9,113,715,197.64 | 4,718,649,816.31 | 16,903,599,007.95 |
| 经营活动产生的现金流量净额 | 4,362,180,976.59 | 2,922,543,071.49 | 1,708,202,556.08 | 5,972,727,509.04 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,347,650,973.56 | 942,586,376.53 | 520,371,882.46 | 2,127,188,249.63 |
| 投资活动现金流出小计 | 2,822,614,290.07 | 1,703,704,252.73 | 1,407,909,281.08 | 5,223,112,388.92 |
| 投资活动产生的现金流量净额 | -1,474,963,316.51 | -761,117,876.2 | -887,537,398.62 | -3,095,924,139.29 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,750,310,731.06 | 283,053,932.23 | 230,094,634.64 | 1,924,244,116.75 |
| 筹资活动现金流出小计 | 4,711,628,225.34 | 2,135,627,121.98 | 1,164,586,938.69 | 4,876,177,868.51 |
| 筹资活动产生的现金流量净额 | -2,961,317,494.28 | -1,852,573,189.75 | -934,492,304.05 | -2,951,933,751.76 |
| 汇率变动对现金及现金等价物的影响 | -23,187,073.3 | -44,729,029.86 | -21,770,642.71 | -5,972,371 |
| 现金及现金等价物净增加额 | -97,286,907.5 | 264,122,975.68 | -135,597,789.3 | -81,102,753.01 |
| 期末现金及现金等价物余额 | 5,182,396,449.63 | 5,543,806,332.81 | 5,144,085,567.83 | 5,279,683,357.13 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 264,122,975.68 | - | -81,102,753.01 |
最新报告期：2026-11-03| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 招商证券 | 梁广楷,许菲菲 | 0.29 | 0.35 | 0.39 | 2026-11-03 |
| 中金公司 | 张琎,张一弛,李千翊 | 0.27 | 0.40 | -- | 2026-10-31 |
| 平安证券 | 叶寅,倪亦道,王钰畅 | 0.33 | 0.44 | 0.48 | 2026-10-30 |
| 中信建投 | 华冉,吴严,刘慧彬,王在存,袁清慧,贺菊颖 | 0.29 | 0.40 | 0.43 | 2026-09-30 |
| 华创证券 | 郑辰,王宏雨 | 0.37 | 0.44 | 0.51 | 2026-09-04 |